115 related articles for article (PubMed ID: 38507997)
41. RL66 a second-generation curcumin analog has potent in vivo and in vitro anticancer activity in ER‑negative breast cancer models.
Yadav B; Taurin S; Larsen L; Rosengren RJ
Int J Oncol; 2012 Nov; 41(5):1723-32. PubMed ID: 22971638
[TBL] [Abstract][Full Text] [Related]
42. Altersolanol B, a fungal tetrahydroanthraquinone, inhibits the proliferation of estrogen receptor-expressing (ER+) human breast adenocarcinoma by modulating PI3K/AKT, p38/ERK MAPK and associated signaling pathways.
Siraj MA; Jacobs AT; Tan GT
Chem Biol Interact; 2022 May; 359():109916. PubMed ID: 35346647
[TBL] [Abstract][Full Text] [Related]
43. MDM2 inhibition in combination with endocrine therapy and CDK4/6 inhibition for the treatment of ER-positive breast cancer.
Portman N; Milioli HH; Alexandrou S; Coulson R; Yong A; Fernandez KJ; Chia KM; Halilovic E; Segara D; Parker A; Haupt S; Haupt Y; Tilley WD; Swarbrick A; Caldon CE; Lim E
Breast Cancer Res; 2020 Aug; 22(1):87. PubMed ID: 32787886
[TBL] [Abstract][Full Text] [Related]
44. Novel derivative of aminobenzenesulfonamide (3c) induces apoptosis in colorectal cancer cells through ROS generation and inhibits cell migration.
Al-Khayal K; Alafeefy A; Vaali-Mohammed MA; Mahmood A; Zubaidi A; Al-Obeed O; Khan Z; Abdulla M; Ahmad R
BMC Cancer; 2017 Jan; 17(1):4. PubMed ID: 28049506
[TBL] [Abstract][Full Text] [Related]
45. Synthesis and SARs study of novel spiro-oxindoles as potent antiproliferative agents with CDK-2 inhibitory activities.
Al-Jassas RM; Islam MS; Al-Majid AM; Nafie MS; Haukka M; Rahman AFMM; Alayyaf AMA; Barakat A
Arch Pharm (Weinheim); 2023 Aug; 356(8):e2300185. PubMed ID: 37253118
[TBL] [Abstract][Full Text] [Related]
46. Molecular hybridization design and synthesis of novel spirooxindole-based MDM2 inhibitors endowed with BCL2 signaling attenuation; a step towards the next generation p53 activators.
Lotfy G; Abdel Aziz YM; Said MM; El Ashry ESH; El Tamany ESH; Abu-Serie MM; Teleb M; Dömling A; Barakat A
Bioorg Chem; 2021 Dec; 117():105427. PubMed ID: 34794098
[TBL] [Abstract][Full Text] [Related]
47. A novel compound, NK150460, exhibits selective antitumor activity against breast cancer cell lines through activation of aryl hydrocarbon receptor.
Fukasawa K; Kagaya S; Maruyama S; Kuroiwa S; Masuda K; Kameyama Y; Satoh Y; Akatsu Y; Tomura A; Nishikawa K; Horie S; Ichikawa Y
Mol Cancer Ther; 2015 Feb; 14(2):343-54. PubMed ID: 25522763
[TBL] [Abstract][Full Text] [Related]
48. Interaction of glucocorticoid receptor (GR) with estrogen receptor (ER) α and activator protein 1 (AP1) in dexamethasone-mediated interference of ERα activity.
Karmakar S; Jin Y; Nagaich AK
J Biol Chem; 2013 Aug; 288(33):24020-34. PubMed ID: 23814048
[TBL] [Abstract][Full Text] [Related]
49. Frequently used antiemetic agent dexamethasone enhances the metastatic behaviour of select breast cancer cells.
Crozier M; Tubman J; Fifield BA; Ferraiuolo RM; Ritchie J; Zuccato K; Mailloux E; Sinha I; Hamm C; Porter LA
PLoS One; 2022; 17(9):e0274675. PubMed ID: 36107918
[TBL] [Abstract][Full Text] [Related]
50. Synthesis and in-vitro anti-cancer evaluations of multi-methoxylated asymmetrical diarylpentanoids as intrinsic apoptosis inducer against colorectal cancer.
Leong SW; Chia SL; Abas F; Yusoff K
Bioorg Med Chem Lett; 2020 Apr; 30(8):127065. PubMed ID: 32127259
[TBL] [Abstract][Full Text] [Related]
51. Phytochemically analysed extract of Ageratina adenophora (Sprengel) R.M.King & H. Rob. initiates caspase 3-dependant apoptosis in colorectal cancer cell: A synergistic approach with chemotherapeutic drugs.
Chanu KD; Thoithoisana S; Kar A; Mukherjee PK; Radhakrishnanand P; Parmar K; Sharma N
J Ethnopharmacol; 2024 Mar; 322():117591. PubMed ID: 38104872
[TBL] [Abstract][Full Text] [Related]
52. Stereoselective Synthesis of the Di-Spirooxindole Analogs Based Oxindole and Cyclohexanone Moieties as Potential Anticancer Agents.
Al-Majid AM; Ali M; Islam MS; Alshahrani S; Alamary AS; Yousuf S; Choudhary MI; Barakat A
Molecules; 2021 Oct; 26(20):. PubMed ID: 34684885
[TBL] [Abstract][Full Text] [Related]
53. Activation of Intrinsic Apoptosis and G1 Cell Cycle Arrest by a Triazole Precursor, N-(4-chlorophenyl)-2-(4-(3,4,5-trimethoxybenzyloxy)benzoyl)-hydrazinecarbothioamide in Breast Cancer Cell Line.
Arulnathan SB; Leong KH; Ariffin A; Kareem HS; Cheah KKH
Anticancer Agents Med Chem; 2020; 20(9):1072-1086. PubMed ID: 32188392
[TBL] [Abstract][Full Text] [Related]
54. A novel synthetic C-1 analogue of 7-deoxypancratistatin induces apoptosis in p53 positive and negative human colorectal cancer cells by targeting the mitochondria: enhancement of activity by tamoxifen.
Ma D; Tremblay P; Mahngar K; Akbari-Asl P; Collins J; Hudlicky T; McNulty J; Pandey S
Invest New Drugs; 2012 Jun; 30(3):1012-27. PubMed ID: 21494837
[TBL] [Abstract][Full Text] [Related]
55. NJK14013, a novel synthetic estrogen receptor-α agonist, exhibits estrogen receptor-independent, tumor cell-specific cytotoxicity.
Kim HI; Kim T; Kim JE; Lee J; Heo J; Lee NR; Kim NJ; Inn KS
Int J Oncol; 2015 Jul; 47(1):280-6. PubMed ID: 25964080
[TBL] [Abstract][Full Text] [Related]
56. Identification of Spiro-Fused [3-azabicyclo[3.1.0]hexane]oxindoles as Potential Antitumor Agents: Initial In Vitro Evaluation of Anti-Proliferative Effect and Actin Cytoskeleton Transformation in 3T3 and 3T3-SV40 Fibroblast.
Knyazev NA; Shmakov SV; Pechkovskaya SA; Filatov AS; Stepakov AV; Boitsov VM; Filatova NA
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34361029
[TBL] [Abstract][Full Text] [Related]
57. Synthesis, Biological Evaluation and In Silico Studies of Certain Oxindole-Indole Conjugates as Anticancer CDK Inhibitors.
Al-Warhi T; El Kerdawy AM; Aljaeed N; Ismael OE; Ayyad RR; Eldehna WM; Abdel-Aziz HA; Al-Ansary GH
Molecules; 2020 Apr; 25(9):. PubMed ID: 32349307
[TBL] [Abstract][Full Text] [Related]
58. Novel cinnamaldehyde-based aspirin derivatives for the treatment of colorectal cancer.
Lu S; Obianom ON; Ai Y
Bioorg Med Chem Lett; 2018 Sep; 28(17):2869-2874. PubMed ID: 30037494
[TBL] [Abstract][Full Text] [Related]
59. Dual drug targeting to kill colon cancers.
Corona SP; Walker F; Weinstock J; Lessene G; Faux M; Burgess AW
Cancer Med; 2022 Jul; 11(13):2612-2626. PubMed ID: 35301819
[TBL] [Abstract][Full Text] [Related]
60. Jatrorrhizine inhibits colorectal carcinoma proliferation and metastasis through Wnt/β-catenin signaling pathway and epithelial-mesenchymal transition.
Wang P; Gao XY; Yang SQ; Sun ZX; Dian LL; Qasim M; Phyo AT; Liang ZS; Sun YF
Drug Des Devel Ther; 2019; 13():2235-2247. PubMed ID: 31371920
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]